Longport, Inc.'s EPISCAN I-200 to be Showcased at Three Conferences

Longport, Inc. (OTC BB: LPTI):

   --  Clinical Symposium in Skin & Wound Care - Las Vegas - October
        23-26

   --  Wound, Ostomy And Continence Nurses Society - Galveston -
        October 22-27

   --  Texas Health Care Association - Dallas - November 7-9

   Longport, Inc., (OTC BB: LPTI), a medical technology specialist in
high resolution ultrasound imaging, announced today that its EPISCAN
I-200 will be showcased at three separate conferences in the coming
weeks.
   Longport will attend and display the EPISCAN I-200 at the annual
Clinical Symposium in Skin & Wound Care in Las Vegas, NV, October
23-26. At this year's conference, organizers expect 1,300
multidisciplinary practitioners - nurses, physicians, podiatrists,
physical therapists, and other professionals who manage skin and wound
care patients across the continuum of health care.
   In addition, Maximum Medical, which has purchased six EPISCAN
I-200 demonstration systems, will showcase the technology at both a
South Central Regional conference of the Wound, Ostomy, and Continence
Nurses Society on October 22-27 in Galveston, TX, and the Texas Health
Care Association meeting on November 7-9 in Dallas, TX.
   Paul Wilson, President of Longport, said, "We are very pleased to
be able to show the EPISCAN I-200 at these conferences, where the
practitioners of wound care can see for themselves how easy it is to
use the scanner, as well as for us to be able to discuss the impact of
the scanner on wound assessment and prevention with a range of
clinicians. Longport is particularly pleased that Maximum Medical is
taking the EPISCAN I-200 to the shows they are attending to reinforce
our sales message. We look forward to attending additional wound
conferences as well as events focused on dermatology and aesthetics in
the near future."

   About Longport, Inc.

   Longport, Inc. of Glen Mills, Pennsylvania, is a medical
technology company that specializes in high resolution ultrasound
imaging. After several years and a multi-million dollar investment in
the technology, Longport has secured patents, copyrights, and FDA
permission to market. The Company's technology has been used to
engineer a unique high resolution ultrasound imaging system. For
further information please contact Longport, Inc. at 1-800-289-6863 or
visit our website at www.longportinc.com.

   Forward-looking Information and the Private Securities Litigation
Reform Act of 1995

   Certain statements in this press release, including statements
concerning product development milestones and anticipated events, are
"forward-looking statements" within the Private Litigation Reform Act
of 1995. Forward Looking Statements are based on the opinions and
estimates of management at the time the statements are made and are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those anticipated in the
forward-looking statements. The words "believe," "expect," "intend,"
"anticipate," variations of such words, and similar expressions
identify forward-looking statements, but their absence does not mean
that the statement is not forward-looking. These statements are not
guarantees of future performance and are subject to certain risks,
uncertainties and assumptions that are difficult to predict. Factors
that could affect Longport's actual results include, among others,
uncertainties as to the Company's ability to manage potential
problems, delays or anticipated expenses, including problems, delays
or expenses involving manufacturing. Readers are cautioned not to
place undue reliance upon these forward-looking statements that speak
only to the date of this release. Reference is made to Longport's 2004
annual report on Form 10-K filed with the Securities and Exchange
Commission for a more definitive description of such factors.
Longport, Inc. undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or
circumstances after the date of this release or to reflect the
occurrence of unanticipated events.